Guardant Health
GH
#1787
Rank
A$16.14 B
Marketcap
A$123.10
Share price
-3.96%
Change (1 day)
79.82%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of December 2025 : -A$0.15 Billion

According to Guardant Health 's latest financial reports the company has -A$0.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-A$0.15 Billion-33.96%
2024-12-31$-A$0.23 Billion-196.39%
2023-12-31$A$0.23 B163.37%
2022-12-31$A$88.43 M-90.06%
2021-12-31$A$0.88 B-49.53%
2020-12-31$A$1.76 B45.56%
2019-12-31$A$1.21 B62.54%
2018-12-31$A$0.74 B88.51%
2017-12-31$A$0.39 B257.53%
2016-12-31$A$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Neogen
NEOG
A$3.06 B-2,219.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$2.49 B-1,824.36%๐Ÿ‡บ๐Ÿ‡ธ USA